These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33202815)

  • 1. Rational Design of a Glycoconjugate Vaccine against Group A
    Di Benedetto R; Mancini F; Carducci M; Gasperini G; Moriel DG; Saul A; Necchi F; Rappuoli R; Micoli F
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
    Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
    ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.
    Nilo A; Passalacqua I; Fabbrini M; Allan M; Usera A; Carboni F; Brogioni B; Pezzicoli A; Cobb J; Romano MR; Margarit I; Hu QY; Berti F; Adamo R
    Bioconjug Chem; 2015 Aug; 26(8):1839-49. PubMed ID: 26230938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine.
    Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R
    Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
    Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
    ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
    Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-driven Convergent Evolution of Polysaccharide-specific "DH-less" B Cells in Glycoconjugate Immunized Mice.
    Kushwaha S; Shome P; Sehgal D
    Immunohorizons; 2024 Aug; 8(8):511-526. PubMed ID: 39093310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.
    Rivera-Hernandez T; Pandey M; Henningham A; Cole J; Choudhury B; Cork AJ; Gillen CM; Ghaffar KA; West NP; Silvestri G; Good MF; Moyle PM; Toth I; Nizet V; Batzloff MR; Walker MJ
    mBio; 2016 Jun; 7(3):. PubMed ID: 27302756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A
    Palmieri E; Kis Z; Ozanne J; Di Benedetto R; Ricchetti B; Massai L; Carducci M; Oldrini D; Gasperini G; Aruta MG; Rossi O; Kontoravdi C; Shah N; Mawas F; Micoli F
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
    Stefanetti G; Rondini S; Lanzilao L; Saul A; MacLennan CA; Micoli F
    Vaccine; 2014 Oct; 32(46):6122-9. PubMed ID: 25192974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group A
    Wang S; Zhao Y; Wang G; Feng S; Guo Z; Gu G
    ACS Infect Dis; 2020 Feb; 6(2):281-290. PubMed ID: 31872763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
    PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoconjugate vaccines: some observations on carrier and production methods.
    MacCalman TE; Phillips-Jones MK; Harding SE
    Biotechnol Genet Eng Rev; 2019 Oct; 35(2):93-125. PubMed ID: 32048549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
    Adamo R
    Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate Vaccine.
    Oldrini D; Del Bino L; Arda A; Carboni F; Henriques P; Angiolini F; Quintana JI; Calloni I; Romano MR; Berti F; Jimenez-Barbero J; Margarit I; Adamo R
    Chemistry; 2020 Jun; 26(31):7018-7025. PubMed ID: 32058627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
    Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P
    Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-plex immunoassay for Group A streptococcus serology and vaccine development.
    Whitcombe AL; Han F; McAlister SM; Kirkham LS; Young PG; Ritchie SR; Atatoa Carr P; Proft T; Moreland NJ
    J Immunol Methods; 2022 Jan; 500():113194. PubMed ID: 34801540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.
    Whang YH; Kim SK; Yoon H; Choi SK; Baik YO; Lee C; Lee I
    PLoS One; 2020; 15(12):e0243909. PubMed ID: 33301525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM
    Beresford NJ; Martino A; Feavers IM; Corbel MJ; Bai X; Borrow R; Bolgiano B
    Vaccine; 2017 Jun; 35(28):3598-3606. PubMed ID: 28408122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.
    Simerska P; Abdel-Aal AB; Fujita Y; Moyle PM; McGeary RP; Batzloff MR; Olive C; Good MF; Toth I
    J Med Chem; 2008 Mar; 51(5):1447-52. PubMed ID: 18278857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.